{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:28:50Z","timestamp":1788571730152,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd015373","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000}}],"reference-count":186,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015373.pub2","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:18:21Z","timestamp":1755483501000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ketamine and other NMDA receptor antagonists for chronic pain"],"prefix":"10.1002","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1832","authenticated-orcid":false,"given":"Michael C","family":"Ferraro","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Medicine and Health; University of New South Wales; Sydney Australia"},{"name":"Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan G","family":"Cashin","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Medicine and Health; University of New South Wales; Sydney Australia"},{"name":"Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J","family":"Visser","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Notre Dame Australia; Fremantle Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Abdel Shaheed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, School of Public Health; University of Sydney; Sydney Australia"},{"name":"Sydney Musculoskeletal Health; University of Sydney and Sydney Local Health District; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Wewege","sequence":"additional","affiliation":[{"name":"Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict M","family":"Wand","sequence":"additional","affiliation":[{"name":"School of Health Sciences; The University of Notre Dame Australia; Fremantle Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia M","family":"Gustin","sequence":"additional","affiliation":[{"name":"Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia"},{"name":"NeuroRecovery Research Hub; School of Psychology, University of New South Wales; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E","family":"O'Connell","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Centre for Health and Wellbeing Across the Lifecourse; Brunel University of London; Uxbridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"McAuley","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Medicine and Health; University of New South Wales; Sydney Australia"},{"name":"Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"issue":"36","key":"10.1002\/14651858.CD015373.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults \u2013 United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S0140-6736(15)60805-4.","article-title":"Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis","volume":"385 Suppl 2","author":"Jackson","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/JPR.S105892","article-title":"A review of chronic pain impact on patients, their social environment and the health care system","volume":"9","author":"Due\u00f1as","year":"2016","journal-title":"Journal of Pain Research"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/PAPR.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0008|cit8","unstructured":"Institute of Medicine Relieving pain in America: a blueprint for transforming prevention, care, education, and research Available at nap.nationalacademies.org\/catalog\/13172\/relieving-pain-in-america-a-blueprint-for-transforming-prevention-care 2011"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0009|cit9","unstructured":"Pezzullo L The cost of pain in Australia. Report for Painaustralia www.painaustralia.org.au\/static\/uploads\/files\/the-cost-of-pain-in-australia-launch-20190404-wfrsaslpzsnh.pdf 2019"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7321-7_1","volume-title":"NMDA Receptors. Methods in Molecular Biology","volume":"1677","author":"Hansen","year":"2017"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"The ketamine story \u2013 past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"European Journal of Anaesthesiology"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AAP.0000000000000808","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Cohen","year":"2018","journal-title":"Regional Anesthesia & Pain Medicine"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"bcr2014207836","DOI":"10.1136\/bcr-2014-207836","article-title":"Oral ketamine analgesia in chronic pain and problematic rise in blood pressure","volume":"2014","author":"Hecke","year":"2014","journal-title":"BMJ Case Reports"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003351.pub3","article-title":"Ketamine as an adjuvant to opioids for cancer pain","author":"Bell","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1213\/ANE.0000000000006851","article-title":"Esketamine: less drowsiness, more analgesia","volume":"139","author":"Mion","year":"2024","journal-title":"Anesthesia & Analgesia"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00044011-200929050-00004","article-title":"Development of a sublingual\/oral formulation of ketamine for use in neuropathic pain","volume":"29","author":"Chong","year":"2009","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1742-7843.2012.00908.x","article-title":"Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine","volume":"111","author":"Peltoniemi","year":"2013","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","article-title":"Metabolism and metabolomics of ketamine: a toxicological approach","volume":"2","author":"Dinis-Oliveira","year":"2017","journal-title":"Forensic Sciences Research"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1399-6576.1997.tb04624.x","article-title":"NMDA receptor antagonists: interactions with opioids","volume":"41","author":"Dickenson","year":"1997","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/bph.12974","article-title":"Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat","volume":"11","author":"Lilius","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/AAP.0000000000000806","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Schwenk","year":"2018","journal-title":"Regional Anesthesia & Pain Medicine"},{"issue":"12","key":"10.1002\/14651858.CD015373.pub2-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012033.pub4","article-title":"Perioperative intravenous ketamine for acute postoperative pain in adults","author":"Brinck","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD015373.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40264-021-01120-9","article-title":"Repeated or continuous medically supervised ketamine administration associated with hepatobiliary adverse events: a retrospective case series","volume":"44","author":"Cotter","year":"2021","journal-title":"Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD015373.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.cgh.2014.01.041","article-title":"Liver injury is common among chronic abusers of ketamine","volume":"12","author":"Wong","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.urology.2007.11.141","article-title":"A pediatric case of ketamine-associated cystitis","volume":"71","author":"Gr\u00e9goire","year":"2008","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell","year":"2018","journal-title":"Pain Reports"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12316","article-title":"Memantine for the treatment of general neuropathic pain: a narrative review","volume":"32","author":"Pickering","year":"2018","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD015373.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/ejp.1795","article-title":"Amantadine prevented hypersensitivity and decreased oxidative stress by NMDA receptor antagonism after spinal cord injury in rats","volume":"25","author":"Mata-Bermudez","year":"2021","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF03018952","article-title":"The role of dextromethorphan in pain control","volume":"47","author":"Weinbroum","year":"2000","journal-title":"Canadian Journal of Anesthesia"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"e112348","DOI":"10.5812\/aapm.112348","article-title":"Utilization of magnesium for the treatment of chronic pain","volume":"11","author":"Urits","year":"2021","journal-title":"Anesthesiology and Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","article-title":"Expanding role of NMDA receptor antagonists in the management of pain","volume":"33","author":"Kreutzwiser","year":"2019","journal-title":"CNS Drugs"},{"issue":"348","key":"10.1002\/14651858.CD015373.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"5","author":"Cohen","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/ALN.0b013e31826a0db3","article-title":"Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers","volume":"117","author":"Niesters","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesthesia & Analgesia"},{"issue":"32","key":"10.1002\/14651858.CD015373.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"e11709","DOI":"10.1097\/MD.0000000000011709","article-title":"Ketamine infusion therapy for chronic pain management in South Korea: a national survey for pain physicians with a narrative review","volume":"97","author":"Anaya","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1515\/sjpain-2021-0079","article-title":"Ketamine therapy for chronic pain in the Netherlands: a nationwide survey","volume":"22","author":"Mangnus","year":"2022","journal-title":"Scandinavian Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0046|cit46","unstructured":"National Institute for Health and Care Excellence Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NG193) www.nice.org.uk\/guidance\/ng193 2021"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0047|cit47","unstructured":"Position Statement on the use of ketamine in the management of chronic non-cancer pain https:\/\/www.anzca.edu.au\/getContentAsset\/f7598d01-4daf-416a-ba4d-093de2bc0e18\/80feb437-d24d-46b8-a858-4a2a28b9b970\/PS12(PM)-Position-statement-on-the-use-of-ketamine-in-the-management-of-chronic-non-cancer-pain.PDF 2022"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ejp.1914","article-title":"Ketamine in chronic pain: a Delphi survey","volume":"26","author":"Voute","year":"2022","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0049|cit49","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0051|cit51","unstructured":"The Center for Scientific Integrity. New York, 2018 Available from: http:\/\/retractiondatabase.org\/"},{"issue":"12","key":"10.1002\/14651858.CD015373.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013756.pub2","article-title":"Implanted spinal neuromodulation interventions for chronic pain in adults","author":"O'Connell","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD015373.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007407.pub4","article-title":"Psychological therapies for the management of chronic pain (excluding headache) in adults","author":"Williams AC de","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0055|cit55","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (chapter last updated March 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1 (updated August 2024). Cochrane, 2025 Available from https:\/\/training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0056|cit56","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0057|cit57","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0059|cit59","unstructured":"WebPlotDigitizer, version 5.2 Automeris 2024"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0060|cit60","unstructured":"Cochrane. Managing potentially problematic studies (updated 16 July 2024) https:\/\/www.cochranelibrary.com\/cdsr\/editorial-policies#problematic-studies (accessed 16 October 2023)"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0061|cit61","unstructured":"Cochrane. Policy for managing potentially problematic studies: implementation guidance https:\/\/www.cochranelibrary.com\/cdsr\/editorial-policies#problematic-studies (accessed 16 October 2024)"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/jrsm.1599","article-title":"Identifying and managing problematic trials: a research integrity assessment tool for randomized controlled trials in evidence synthesis","volume":"14","author":"Weibel","year":"2023","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0063|cit63","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0065|cit65","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD015373.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3899\/jrheum.141440","article-title":"Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshop","volume":"42","author":"Busse","year":"2015","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0068|cit68","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0069|cit69","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","volume":"1","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"Journal of Statistical Software"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0071|cit71","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0073|cit73","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1185\/03007998009109493","article-title":"A controlled trial of magnesium dithiosalicylate compared with aspirin in rheumatoid arthritis","volume":"6","author":"Dequeker","year":"1980","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-021-05814-4","article-title":"The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial","volume":"22","author":"Javorcikova","year":"2021","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0076|cit76","unstructured":"ESKETamine for FIBromyalgia Treatment (ESKEFIB) https:\/\/clinicaltrials.gov\/study\/NCT04436250"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00002508-200309000-00007","article-title":"A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain","volume":"19","author":"Lynch","year":"2003","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000542-200507000-00021","article-title":"Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial","volume":"103","author":"Lynch","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00000542-200603000-00021","article-title":"Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain","volume":"104","author":"Gottrup","year":"2006","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"e007087","DOI":"10.1136\/bmjopen-2014-007087","article-title":"Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial)","volume":"5","author":"Juel","year":"2015","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0081|cit81","unstructured":"RESET Trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2013-003357-17-DK"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00000539-200010000-00036","article-title":"Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study","volume":"91","author":"Nikolajsen","year":"2000","journal-title":"Anesthesia and Analgesia"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(01)00455-9","article-title":"Analgesic effects of dextromethorphan and morphine in patients with chronic pain","volume":"96","author":"Heiskanen","year":"2002","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0084|cit84","unstructured":"Ketamine's efficiency in the treatment of chronic pain with inflammatory component: exploring the kynurenin pathways. A controlled, placebo-controlled, double-blind trial clinicaltrialsregister.eu\/ctr-search\/trial\/2017-003930-10\/FR"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0085|cit85","unstructured":"Ketamine's efficiency in the treatment of chronic pain: kynurenin pathway (KEKU1) clinicaltrials.gov\/study\/NCT03513822"},{"issue":"10","key":"10.1002\/14651858.CD015373.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/nu14102088","article-title":"Short-term magnesium therapy alleviates moderate stress in patients with fibromyalgia: a randomized double-blind clinical trial","volume":"14","author":"Macian","year":"2022","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0087|cit87","unstructured":"Magnesium, stress and fibromyalgia (SeMAFor) clinicaltrials.gov\/show\/NCT03887000"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cct.2014.06.004","article-title":"Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients","volume":"38","author":"Pickering","year":"2014","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0089|cit89","unstructured":"Study of NMDA antagonists and neuropathic Pain (NMDA) clinicaltrials.gov\/study\/NCT01602185"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/DDDT.S207350","article-title":"Dextromethorphan and memantine after ketamine analgesia: a randomized control trial","volume":"13","author":"Martin","year":"2019","journal-title":"Drug Design, Development and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0091|cit91","first-page":"151","article-title":"Effects of intravenous ketamine administered for three days in patients with fibromyalgic pain: double-blind, crossover study versus placebo","volume":"6","author":"Muller","year":"2005","journal-title":"Douleurs"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0092|cit92","unstructured":"Oral ketamine administration in patients with peripheral neuropathic pain clinicaltrials.gov\/study\/NCT00961194"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ALN.0000000000003345","article-title":"Ketamine and magnesium for refractory neuropathic pain: a randomized, double-blind, crossover trial","volume":"133","author":"Pickering","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0094|cit94","unstructured":"Ketamine and neuropathic pain (KETAPAIN) clinicaltrials.gov\/study\/NCT02467517"},{"issue":"517","key":"10.1002\/14651858.CD015373.pub2-BIB0095|cit95","first-page":"1","article-title":"Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial","volume":"18","author":"Delage","year":"2017","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2010.06.022","article-title":"NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation","volume":"151","author":"Gustin","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1213\/01.ane.0000196691.82989.67","article-title":"Amantadine sulfate reduces experimental sensitization and pain in chronic back pain patients","volume":"102","author":"Kleinb\u00f6hl","year":"2006","journal-title":"Anesthesia & Analgesia"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0098|cit98","first-page":"277","article-title":"Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain \u2013 results of a randomized double-blinded, placebo controlled trial","volume":"3","author":"Maier","journal-title":"2003"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"179-84","DOI":"10.1034\/j.1600-0404.2003.00114.x","article-title":"NMDA-mediated mechanisms in cortical excitability changes after limb amputation","volume":"108","author":"Schwenkreis","year":"2003","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1213\/01.ANE.0000096002.53818.BD","article-title":"A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain","volume":"98","author":"Wiech","year":"2004","journal-title":"Anesthesia & Analgesia"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1090-3801(98)90030-1","article-title":"The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study","volume":"2","author":"Eisenberg","year":"1998","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00115550-199924060-00011","article-title":"Intravenous lidocaine, amantadine, and placebo in the treatment of sciatica: a double-blind, randomized, controlled study","volume":"24","author":"Medrik-Goldberg","year":"1999","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"8","key":"10.1002\/14651858.CD015373.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/BF03017431","article-title":"Short- and long-term efficacy of oral ketamine in eight chronic-pain patients","volume":"49","author":"Furuhashi-Yonaha","year":"2002","journal-title":"Canadian Journal of Anesthesia"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00540-004-0273-1","article-title":"Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine","volume":"19","author":"Hayashida","year":"2005","journal-title":"Journal of Anesthesia"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0105|cit105","unstructured":"Efficacy of low-dose ketamine intravenous injection under nerve root block trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000018308"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/pme.12211","article-title":"Intravenous magnesium for chronic complex regional pain syndrome type 1 (CRPS-1)","volume":"1489","author":"Fischer","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0107|cit107","unstructured":"Effects of continuous intravenous magnesium on features of central sensitisation in complex regional pain syndrome type one patients trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN66289967"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/bja\/aes578","article-title":"Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study","volume":"110","author":"Niesters","year":"2013","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0109|cit109","unstructured":"DNIC and offset analgesia study onderzoekmetmensen.nl\/en\/trial\/28485"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejpain.2011.03.008","article-title":"Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial","volume":"15","author":"Noppers","year":"2011","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0111|cit111","unstructured":"Fibromyalgia ketstudy onderzoekmetmensen.nl\/en\/trial\/22499"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"issue":"11","key":"10.1002\/14651858.CD015373.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jpain.2013.05.013","article-title":"An explanatory study evaluating the muscle relaxant effects of intramuscular magnesium sulphate for dystonia in complex regional pain syndrome","volume":"14","author":"Van Der Plas","year":"2013","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0114|cit114","unstructured":"Double-blind randomised placebo-controlled cross-over study to investigate the effectiveness of intramuscular magnesium on pain and dystonia in complex regional pain syndrome type 1 onderzoekmetmensen.nl\/en\/trial\/22797"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.0001-5172.2004.0325.x","article-title":"Analgesic effect of dextromethorphan in neuropathic pain","volume":"48","author":"Carlsson","year":"2004","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0304-3959(94)90129-5","article-title":"Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo","volume":"58","author":"Eide","year":"1994","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0117|cit117","first-page":"242","article-title":"Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross over comparison with morphine and placebo","volume":"2","author":"Eide","year":"1995","journal-title":"Revista de la Sociedad Espa\u00f1ola de Dolor"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1227\/00006123-199512000-00007","article-title":"Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation","volume":"37","author":"Eide","year":"1995","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3959(02)00122-7","article-title":"Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-d-aspartate (NMDA) receptor antagonist ketamine \u2013 a double-blind, cross-over comparison with alfentanil and placebo","volume":"101","author":"J\u00f8rum","year":"2003","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD015373.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","article-title":"Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up","volume":"155","author":"Olivan-Bl\u00e1zquez","year":"2014","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0121|cit121","unstructured":"Evaluation of the efficacy of memantine in the treatment of fibromyalgia: a double-blind randomized control clinical trial trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2011-006244-73-ES"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0122|cit122","unstructured":"Randomised controlled trial of memantine in fibromyalgia clinicaltrials.gov\/study\/NCT01653457"},{"issue":"11","key":"10.1002\/14651858.CD015373.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/cns.12314","article-title":"Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up","volume":"20","author":"Fayed","year":"2014","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-3","article-title":"Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up","volume":"14","author":"Olivan-Bl\u00e1zquez","year":"2013","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Graven-Nielsen","year":"2000","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1034\/j.1399-6576.2003.00187.x","article-title":"The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain","volume":"47","author":"Kvarnstr\u00f6m","year":"2003","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1399-6576.2003.00330.x","article-title":"The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury","volume":"48","author":"Kvarnstr\u00f6m","year":"2004","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.ajp.0000126155.82815.fc","article-title":"The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain","volume":"21","author":"Lemming","year":"2005","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjpain.2012.01.003","article-title":"Whiplash Associated Disorders (WAD): responses to pharmacological challenges and psychometric tests","volume":"3","author":"Persson","year":"2012","journal-title":"Scandinavian Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749509095181","article-title":"Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine","volume":"24","author":"S\u00f6rensen","year":"1995","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD015373.pub2-BIB0131|cit131","first-page":"1615","article-title":"Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs","volume":"24","author":"S\u00f6rensen","year":"1997","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1213\/ane.0b013e3181685014","article-title":"Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds","volume":"106","author":"Eichenberger","year":"2008","journal-title":"Anesthesia & Analgesia"},{"issue":"Suppl 16","key":"10.1002\/14651858.CD015373.pub2-BIB0133|cit133","first-page":"O7","article-title":"Efect of magnesium supplementation on diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of diabetic patients with hypomagnesemia","volume":"17","author":"Hussain","year":"2023","journal-title":"BMC Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1464-5491.2003.00882.x","article-title":"A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy","volume":"20","author":"Amin","year":"2003","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/bja\/89.5.711","article-title":"Efficacy of intravenous magnesium in neuropathic pain","volume":"89","author":"Brill","year":"2002","journal-title":"British Journal of Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(99)00117-7","article-title":"N of 1 randomised controlled trials of oral ketamine in patients with chronic pain","volume":"83","author":"Haines","year":"1999","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90056-6","article-title":"Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design","volume":"59","author":"McQuay","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(94)90149-X","article-title":"Response of chronic neuropathic pain syndromes to ketamine: a preliminary study","volume":"56","author":"Backonja","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0140|cit140","first-page":"113a","article-title":"Efficacy and safety of intranasal ketamine for the management of breakthrough pain in chronic pain. A randomized, double blind, placebo-controlled, crossover trial","volume":"21","author":"Goudas","year":"2002","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2470547020981670","article-title":"Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial","volume":"4","author":"Dadabayev","year":"2020","journal-title":"Chronic Stress"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0142|cit142","unstructured":"Ketamine infusion for comorbid PTSD and chronic pain clinicaltrials.gov\/study\/NCT04322968"},{"issue":"7","key":"10.1002\/14651858.CD015373.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.55.7.964","article-title":"A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias","volume":"55","author":"Gilron","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0144|cit144","unstructured":"Studies of dextromethorphan and topiramate to treat oral and facial pain clinicalTrials.gov\/show\/NCT00001725"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jpain.2016.01.394","article-title":"Oral ketamine for chronic pain: a 32-subject placebo-controlled trial in patients on chronic opioids","volume":"17","author":"Grande","year":"2016","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0146|cit146","unstructured":"Ultra-low dose oral ketamine for chronic pain in the primary care setting (ketamine) clinicaltrials.gov\/study\/NCT02303847"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1526-4637.2002.202423.x","article-title":"Memantine in the treatment of diabetics with painful peripheral neuropathy: a placebo-controlled phase IIb trial","volume":"3","author":"Kirby","year":"2002","journal-title":"Pain Medicine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD015373.pub2-BIB0148|cit148","first-page":"A82","article-title":"Memantine in the treatment of diabetic peripheral neuropathy: a placebo-controlled phase IIB trial","volume":"54","author":"Pellegrino","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD015373.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3959(00)00433-4","article-title":"Concentration\u2013effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain","volume":"91","author":"Leung","year":"2001","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD015373.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/acem.13755","article-title":"Subdissociative-dose ketamine is effective for treating acute exacerbations of chronic pain","volume":"26","author":"Lumanauw","year":"2019","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0151|cit151","unstructured":"Subdissociative dose ketamine for treatment of acute pain in subjects with chronic pain clinicaltrials.gov\/show\/NCT02920528"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7547\/1020178","article-title":"Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study","volume":"102","author":"Mahoney","year":"2012","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00002826-199508000-00008","article-title":"Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo","volume":"18","author":"Max","year":"1995","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0154|cit154","unstructured":"Clinical neuropharmacology of pain in spinal cord injury- dextromethorphan dose response clinical trial clinicaltrials.gov\/study\/NCT01435798"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0155|cit155","unstructured":"Clinical neuropharmacology of pain in spinal cord injury- dextromethorphan\/\u200blidocaine combination clinical trial clinicaltrials.gov\/study\/NCT02218203"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0156|cit156","first-page":"1212","article-title":"High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia","volume":"5","author":"Nelson","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","article-title":"Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials","volume":"96","author":"Sang","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0158|cit158","unstructured":"Dextromethorphan versus placebo for neuropathic pain clinicaltrials.gov\/study\/NCT00001344"},{"issue":"4","key":"10.1002\/14651858.CD015373.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","article-title":"A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy","volume":"12","author":"Schifitto","year":"2006","journal-title":"Journal of Neurovirology"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0160|cit160","doi-asserted-by":"crossref","DOI":"10.21236\/AD1012239","volume-title":"A double-blind randomized placebo controlled trial of magnesium oxide for alleviation of chronic low back pain [Masters thesis]","author":"Schrader","year":"1999"},{"issue":"147","key":"10.1002\/14651858.CD015373.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.08.015","article-title":"Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study","volume":"15","author":"Schwartzman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0162|cit162","unstructured":"Double blind placebo controlled study of outpatient intravenous ketamine for the treatment of CRPS clinicaltrials.gov\/study\/NCT00579085"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0163|cit163","first-page":"E315","article-title":"The use of intravenous magnesium for the treatment of fibromyalgia","volume":"13","author":"Voogd","year":"2010","journal-title":"Pain Physician"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0164|cit164","first-page":"529","article-title":"The use of intravenous magnesium for the treatment of fibromyalgia","volume":"7","author":"Voogd","year":"2010","journal-title":"Gender Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0165|cit165","first-page":"207","article-title":"Management of neuropathic chronic pain with methadone combined with ketamine: a randomized, double blind, active-controlled clinical trial","volume":"20","author":"Rigo","year":"2017","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0166|cit166","unstructured":"Methadone and ketamine for neuropathic pain treatment clinicaltrials.gov\/study\/NCT02233452"},{"issue":"7","key":"10.1002\/14651858.CD015373.pub2-BIB0167|cit167","first-page":"214","article-title":"Evaluation of oral ketamine for the treatment of neuropathic pain","volume":"65","author":"Tonet","year":"2008","journal-title":"Revista Brasileira de Medicina"},{"issue":"S1","key":"10.1002\/14651858.CD015373.pub2-BIB0168|cit168","first-page":"127","article-title":"Double blinded randomized study comparing the effects of low dose ketamine infusion in patients with neuropathic low back pain","volume":"9","author":"Yousef","year":"2009","journal-title":"Pain Practice"},{"issue":"4S","key":"10.1002\/14651858.CD015373.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-5347(09)60353-0","article-title":"Memantine in the alleviation of symptoms of chronic pelvic pain syndrome: a randomized, double-blind placebo-controlled trial","volume":"181","author":"Dimitrakov","year":"2009","journal-title":"Journal of Urology"},{"issue":"11","key":"10.1002\/14651858.CD015373.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"e076754","DOI":"10.1136\/bmj-2023-076754","article-title":"ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis","volume":"383","author":"Page","year":"2023","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD015373.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","article-title":"Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system","volume":"162","author":"Kosek","year":"2021","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD015373.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"e2314406","DOI":"10.1001\/jamanetworkopen.2023.14406","article-title":"Assessment of initial depressive state and pain relief with ketamine in patients with chronic refractory pain","volume":"6","author":"Voute","year":"2023","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/pm\/pny024","article-title":"Intravenous ketamine infusion for complex regional pain syndrome: survey, consensus, and a reference protocol","volume":"20","author":"Xu","year":"2018","journal-title":"Pain Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015373.pub2-BIB0174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015373","article-title":"Ketamine and other NMDA receptor antagonists for chronic pain","author":"Ferraro","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jphys.2023.04.001","article-title":"Who should judge treatment effects as unimportant?","volume":"69","author":"Abdel Shaheed","year":"2023","journal-title":"Journal of Physiotherapy"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(02)00033-7","article-title":"A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial","volume":"97","author":"Mitchell","year":"2002","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"245","DOI":"10.36076\/ppj.2010\/13\/245","article-title":"Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial","volume":"13","author":"Amr","year":"2010","journal-title":"Pain Physician"},{"issue":"7","key":"10.1002\/14651858.CD015373.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ejp.1393","article-title":"A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain","volume":"23","author":"Kurian","year":"2019","journal-title":"European Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD015373.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1213\/ANE.0000000000004673","article-title":"Efficacy and safety of magnesium for the management of chronic pain in adults: a systematic review","volume":"131","author":"Park","year":"2020","journal-title":"Anesthesia & Analgesia"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"102127","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"102496","DOI":"10.1016\/j.mex.2023.102496","article-title":"Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research","volume":"12","author":"Karran","year":"2024","journal-title":"MethodsX"},{"issue":"7","key":"10.1002\/14651858.CD015373.pub2-BIB0182|cit182","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41386-019-0317-8","article-title":"Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant","volume":"44","author":"Wilkinson","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD015373.pub2-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.eclinm.2023.102340","article-title":"Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent\/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process","volume":"66","author":"Bova","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"6","key":"10.1002\/14651858.CD015373.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/j.pain.0000000000000866","article-title":"Recommendations for a first core outcome measurement set for complex regional pain syndrome clinical studies (COMPACT)","volume":"158","author":"Grieve","year":"2017","journal-title":"Pain"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"e073725","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015373.pub2-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:17:38Z","timestamp":1786598258000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015373.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":186,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015373.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}